Investigational Site Number : 7560002

Zurich 8091

0 studies enrolling now · 2 studies all time

What they study most

Eosinophilic Oesophagitis, Glycogen Storage Disease Type II;Pompe's Disease

Studies at this site

• A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) — Running, not enrolling
• Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease — Completed